Filing Flows › Humana (HUM) › Q2 2026 › vs Q1 2026
Humana (HUM) Q2 2026 vs Q1 2026 (quarter over quarter)
Humana's revenue rose $1.2B (+3%) from $39.6B in Q1 2026 to $40.9B in Q2 2026. Operating margin 3.3% against 4.4% (-1.1 pts).
Humana, Q2 2026: revenue $40.9B (+26% year over year), operating margin 3.3%, net earnings $693M, operating cash flow $2.0B. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Operating margin | 3.3% | 4.4% | -1.1 pts |
| Net margin | 1.7% | 3.0% | -1.3 pts |
| Free cash flow margin | 4.5% | 2.9% | +1.6 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $40.9B | $39.6B | $1.2B | +3% |
| Operating profit | $1.4B | $1.8B | −$394M | -22% |
| Costs & expenses | $39.5B | $37.9B | $1.6B | +4% |
| Pre-tax earnings | $931M | $1.6B | −$648M | -41% |
| Other expense, net | $429M | $175M | $254M | +145% |
| SG&A | $4.0B | $4.0B | −$46.0M | -1% |
| Other operating costs | $35.5B | $33.9B | $1.7B | +5% |
| Net earnings | $693M | $1.2B | −$491M | -41% |
| Income tax | $238M | $395M | −$157M | -40% |
| Depreciation & amortization | $159M | $163M | −$4.0M | -2% |
| Share-based compensation | $65.0M | $51.0M | $14.0M | +27% |
| Working capital & other | $1.0B | −$144M | $1.2B | — |
| Operating cash flow | $2.0B | $1.3B | $712M | +57% |
| Free cash flow (OCF − capex) | $1.8B | $1.1B | $701M | +62% |
| Capital expenditures | $132M | $121M | $11.0M | +9% |
Questions
How much did Humana's revenue grow quarter over quarter in Q2 2026?
Humana's revenue rose $1.2B (+3%) from $39.6B in Q1 2026 to $40.9B in Q2 2026. Operating margin 3.3% against 4.4% (-1.1 pts).